BAMS
INFI

Bellevue Asset Management (Switzerland)’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Bellevue Asset Management (Switzerland)’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		$1.26M Buy
160,000
+30,000
+23% +$258K 0.19% 97
2015
Q3 		$1.1M Sell
130,000
-34,000
-21% -$314K 0.18% 103
2015
Q2 		$1.8M Hold
164,000
– – 0.25% 90
2015
Q1 		$2.29M Buy
+164,000
New +$2.51M 0.32% 78

Other funds holding INFI

ACM
Americafirst Capital Management Roseville, California $74M AUM 30.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bellevue Asset Management (Switzerland)'s INFI Position: Q4 2015 in Review

Bellevue Asset Management (Switzerland) increased its Infinity Pharmaceuticals, Inc. (INFI) stake by 23% in Q4 2015, buying an estimated $258K and bringing the position to 160,000 shares worth $1.26M. The position accounts for 0.19% of the portfolio, ranked #97.

Bellevue Asset Management (Switzerland) first reported a position in INFI in Q1 2015 and has held it in 4 quarters since. The position peaked at $2.29M in Q1 2015. 115 funds tracked by Wall St. Rank hold INFI as of Q4 2015.

  • Bellevue Asset Management (Switzerland) held 160,000 shares of Infinity Pharmaceuticals, Inc. worth $1.26M as of Q4 2015.
  • Bellevue Asset Management (Switzerland) bought 30,000 Infinity Pharmaceuticals, Inc. shares in Q4 2015, an estimated $258K.
  • Infinity Pharmaceuticals, Inc. made up 0.19% of Bellevue Asset Management (Switzerland)'s portfolio in Q4 2015, its #97 holding.
  • Bellevue Asset Management (Switzerland) first reported a position in Infinity Pharmaceuticals, Inc. in Q1 2015 and has held it in 4 quarters since.
  • Bellevue Asset Management (Switzerland)'s Infinity Pharmaceuticals, Inc. position peaked at $2.29M in Q1 2015.
  • 115 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2015.

Based on Bellevue Asset Management (Switzerland)'s 13F filing for Q4 2015, filed 12 Feb 2016.